Dublin Core
Title
Apheresis in Neurological Disorders
Subject
Neurology
Description
Apheresis refers to an extracorporeal therapy which aims at removing pathological constituents from the patients’ blood. Due to the development of new techniques as well as the discovery of novel autoimmune antibodies, it is increasingly recognized as an important therapeutic option for a variety of autoimmune-mediated neurological disorders, including multiple sclerosis, myasthenia gravis, autoimmune encephalitis, Guillain–Barré syndrome, and many others. Therapeutic plasma exchange (TPE) constitutes the standard method of apheresis for most indications, while immunoadsorption (IA) offers a more specific, low-risk alternative. Both methods aim at removing auto-antibodies from the blood. Evidence for most neurological diseases is still low. Interestingly, more recent developments suggest that apheresis is not limited to the removal of autoantibodies but may also be useful in neurodegenerative and possibly even in acute vascular disorders.
Creator
Dorst, Johannes (editor)
Source
https://directory.doabooks.org/handle/20.500.12854/69367
Publisher
MDPI - Multidisciplinary Digital Publishing Institute
Date
2020
Contributor
Sukartini
Rights
https://creativecommons.org/licenses/by/4.0/
Format
Pdf
Language
English
Type
Textbooks
Identifier
DOI 10.3390/books978-3-03943-586-9
ISBN 9783039435852, 9783039435869
ISBN 9783039435852, 9783039435869